Buy the pullback in this large pharma stock: UBS

September 17, 2026 6:00 AM

UBS maintained its Buy rating on a major pharmaceutical company after a series of clinical trial failures and merger speculation ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found